BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Tuesday, March 19, 2024
Home
»
Newsletters
» BioWorld Asia
BioWorld Asia
Jan. 9, 2002
View Archived Issues
PPL Clones Knockout Pigs, Says Dolly’s Arthritis Not A Setback
Read More
New Heart Drugs Could Be Hiding In A Glass Of Vin Rouge
Read More
NeuTec Raising 10M To Fund Programs Targeting Infections
Read More
Budget Cuts Sidetrack Plan For Israeli Biotech Institute
Read More
Antisoma, Abbott Restructure Deal Regarding Cancer Drug
Read More
Novartis Enlists Optimata To Analyze New Drug Candidates
Read More
Strakan Raises Another £15M, Gains UK Approval For Zindaclin
Read More
ExonHit Partners With IDEC To Develop Antibody Therapeutics
PARIS - ExonHit Therapeutics SA and IDEC Pharmaceuticals Corp. signed a collaboration and research agreement aimed at discovering new antigen targets for antibody therapy, with a particular focus on prostate carcinoma.
Read More
Other News To Note
Read More